Warning For Facebook “Like” Reflects FDA Social Media Approach
This article was originally published in The Tan Sheet
Executive Summary
FDA is revealing its views on social media use through individual enforcement actions and provisions in disparate guidances, in the absence of issuing an overarching guidance. A recent warning letter sheds light on the agency’s view of “liking” something on Facebook.
You may also be interested in...
Social Media Guidance Gives Drug Firms A Pass On User Content
The draft guidance outlines substantial reporting requirements for websites that firms control and for content on third-party sites – as well as saying when FDA intends to use enforcement discretion.
Social Media Guidance Gives Drug Firms A Pass On User Content
The draft guidance outlines substantial reporting requirements for websites that firms control and for content on third-party sites – as well as saying when FDA intends to use enforcement discretion.
Firms’ Liability For User-Generated Content Remains Regulatory Gray Area
As consumer-created online content grows, advertisers question their legal responsibilities. While experts have different opinions on firms’ liability, NAD says it allows marketers no immunity from a consumer’s claim posted on its website.